Mapelli, V. 2007. Costs and efficacy ofolanzapine and risperidone in schizophrenia. Farmeconomia. Health economics and therapeutic pathways. 8, 2 (Jun. 2007), 53–60. DOI:https://doi.org/10.7175/fe.v8i2.241.